Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 3:24 pm Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | ARMISTICE CAPITAL LLC | 8,083,946 9.990% | 8,083,946 (New Position) | View |
2024-11-13 07:55 am Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Ruck Matthew J | 275,838 5.180% | 275,838 (New Position) | View |
2024-02-12 10:06 am Sale | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Ness Kevin Dean | 3,060,000 6.250% | -600,000 (-16.39%) | View |
2023-04-05 10:47 am Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Ness Kevin Dean | 3,660,000 9.980% | 360,000 (+10.91%) | View |
2022-02-14 4:05 pm Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Abbhi Investments LLC | 2,425,853 6.690% | 53,445 (+2.25%) | View |
2022-02-04 4:08 pm Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Ness Kevin Dean | 3,300,000 9.100% | 3,300,000 (New Position) | View |
2021-07-12 08:29 am Sale | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | BlackRock Inc. BLK | 474,347 1.300% | -1,445,993 (-75.30%) | View |
2021-02-02 3:13 pm Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | BlackRock Inc. BLK | 1,920,340 6.100% | 1,920,340 (New Position) | View |
2020-05-08 12:04 pm Purchase | 13D | BRAINSTORM CELL THERAPEUTICS I BCLI | Daly Joseph Patrick | 1,077,500 3.660% | 42,319 (+4.09%) | View |
2020-04-08 06:01 am Purchase | 13D | BRAINSTORM CELL THERAPEUTICS I BCLI | Abbhi Investments LLC | 2,372,408 9.040% | 4,657 (+0.20%) | View |
2020-03-17 9:30 pm Purchase | 13G | BRAINSTORM CELL THERAPEUTICS I BCLI | Abbhi Investments LLC | 2,367,751 9.030% | 2,367,751 (New Position) | View |